Cargando…

Effect of COVID-19 on patients with compensated chronic liver diseases

BACKGROUND AND AIM: Cytokine storm has been reported in patients with coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We examine the incidence of acute on chronic liver failure (ACLF) in COVID-19 patients with pre-existing compensate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Dong, Zhang, Dawei, Yang, Tieniu, Mu, Jinsong, Zhao, Peng, Xu, Jing, Li, Chen, Cheng, Gregory, Wang, Yudong, Chen, Zhu, Qin, Enqiang, Lau, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391917/ https://www.ncbi.nlm.nih.gov/pubmed/32734407 http://dx.doi.org/10.1007/s12072-020-10058-6

Ejemplares similares

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
por: Ji, Dong, et al.
Publicado: (2020)

Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19
por: Ji, Dong, et al.
Publicado: (2021)

Reply to: ‘Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis’
por: Ji, Dong, et al.
Publicado: (2020)

Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
por: Thanapirom, Kessarin, et al.
Publicado: (2021)

Clinical value of predictive models based on liver stiffness measurement in predicting liver reserve function of compensated chronic liver disease
por: Lai, Rui-Min, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study
por: Ji, Dong, et al.
Publicado: (2021)

Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B
por: Bi, Jingfeng, et al.
Publicado: (2017)

Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”
por: Ji, Dong, et al.
Publicado: (2021)

Assessment of compensated advanced chronic liver disease based on serum bile acids in chronic hepatitis B patients
por: Chen, Fei, et al.
Publicado: (2023)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept “Compensated Advanced Chronic Liver Disease”
por: Fujita, Koji, et al.
Publicado: (2021)

Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosis
por: Xie, Yangxin, et al.
Publicado: (2017)

Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
por: Liu, Hongling, et al.
Publicado: (2020)

Compensation for Work-Related Hematologic, Liver, and Infectious Diseases
por: Kim, Jung-Won, et al.
Publicado: (2014)

Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection
por: Xie, Yangxin, et al.
Publicado: (2017)

Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Dark-Channel Enhanced-Compensation Net: An end-to-end inner-reflection compensation method for immersive projection system
por: Zhang, Xiangmei, et al.
Publicado: (2022)

The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis
por: Chang, Ya-Chun, et al.
Publicado: (2022)

Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease
por: Margini, Cristina, et al.
Publicado: (2018)

Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals
por: Pons, Mònica, et al.
Publicado: (2017)

Liver stiffness and thrombin generation in compensated cirrhosis
por: Dillon, Audrey, et al.
Publicado: (2019)

Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis
por: Lee, Hong Sub, et al.
Publicado: (2010)

Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia
por: Ismail, Mona
Publicado: (2023)

Liver Regeneration: Analysis of the Main Relevant Signaling Molecules
por: Tao, Yachao, et al.
Publicado: (2017)

Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA
por: Zhou, Jing, et al.
Publicado: (2022)

Characterization of intrahepatic B cells in acute-on-chronic liver failure
por: Zhao, Yudong, et al.
Publicado: (2022)

Improvement of glucose and lipid metabolism with pegylated interferon-α plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus
por: Qing, Shao, et al.
Publicado: (2015)

Obesity and chronic diarrhea: a new syndrome?
por: Linghu, Enqiang
Publicado: (2022)

Reply to: ‘NAFLD or comorbidities, that is the question’
por: Ji, Dong, et al.
Publicado: (2020)

Microbiological Characteristics and Antibiotic Sensitivity in Patients with Nosocomial Spontaneous Bacterial Peritonitis Caused by Escherichia coli: A Multicenter Study
por: Tu, Bo, et al.
Publicado: (2020)

Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting
por: Gayam, Vijay, et al.
Publicado: (2018)

Small Bowel Abnormalities in Patients with Compensated Liver Cirrhosis
por: Aoyama, Taiki, et al.
Publicado: (2012)

Heterotopic lung transplant: a feasible approach to compensate for organ shortages
por: Zhao, Jin, et al.
Publicado: (2022)

THE ASSESMENT OF CHRONIC ILLNESS WITHIN THE COMPENSATION SYSTEM
por: Scott, Bruce D.
Publicado: (1994)

Neutrophil–lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system
por: Fan, Zeng, et al.
Publicado: (2017)

Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection
por: Couto, Ingrid, et al.
Publicado: (2017)

Naoxuekang, Xinnaoshutong and Xuesaitong capsules for treating stroke: a protocol for a randomised controlled trial
por: Chen, Huiling, et al.
Publicado: (2017)

Brain Structural Network Compensation Is Associated With Cognitive Impairment and Alzheimer’s Disease Pathology
por: Sheng, Xiaoning, et al.
Publicado: (2021)

Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
por: Wong, Yu Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3i2ithul1qk62uruds3gpe6kve